Fostamatinib
Drug timelines are a Plus or Pro feature.
42 regulatory and trial events tracked for Fostamatinib, covering 2009-04-20 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Syk Inhibition in MItigating Lung Allograft Rejection (SIMILAR): A Trial to Evaluate the Safety and Tolerability of Fostamatinib in Lung Transplant Patients With Donor-Specific Antibodies [Phase 1]